Semaglutide × peptide crafters — lab test, May 2024
Janoshik Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 5 mg · Lab measured 5 mg
100% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 1.3 mg on both the label figure and the measured one.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of Semaglutide from peptide crafters, performed by Janoshik Labs on May 29, 2024. Reported purity: 99.942%. Net content: 5 mg against 5 mg labeled (100% of label). Batch PC-G-S5. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Semaglutide from peptide crafters
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| PC-G4-S5 | 19 Mar 2026 | Janoshik Labs | 99.658% | 108% | Unverified |
| PC-G2-S10 | 27 Feb 2026 | Janoshik Labs | 99.67% | 104% | Unverified |
| PC-G3-S20 | 9 Feb 2026 | Janoshik Labs | 99.735% | 107% | Unverified |
| PC-G3-S5 | 21 Jan 2026 | Vanguard Laboratory | 99.8% | 120% | Unverified |
| PC-G2-S20 | 19 Dec 2025 | Janoshik Labs | 99.814% | 101% | Unverified |
| PC-G2-S5 | 25 Nov 2025 | Janoshik Labs | 99.461% | 111% | Unverified |
| PC-G1-S10 | 20 Oct 2025 | Janoshik Labs | 99.211% | 108% | Unverified |
| PC-G1-S20 | 2 Oct 2025 | Janoshik Labs | 99.904% | 116% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion